CLONOSEQ
Total Payments
$79,000
Transactions
5
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $7,000 | 2 | 0 |
| 2023 | $72,000 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $72,000 | 3 | 91.1% |
| Space rental or facility fees (teaching hospital only) | $7,000 | 2 | 8.9% |
Payments by Type
Research
$72,000
3 transactions
General
$7,000
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 18281_R | Adaptive Biotechnologies Corporation | $45,600 | 0 |
| COG_AALL1731_R | Adaptive Biotechnologies Corporation | $13,200 | 0 |
| MDAnderson_PA19-0148_R | Adaptive Biotechnologies Corporation | $13,200 | 0 |
Top Doctors Receiving Payments for CLONOSEQ
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Dallas, TX | $79,000 | 5 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $79,000
- Total Doctors 0
- Transactions 5
About CLONOSEQ
CLONOSEQ is a device associated with $79,000 in payments to 0 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is Adaptive Biotechnologies Corporation.
Payment data is available from 2023 to 2024. In 2024, $7,000 was paid across 2 transactions to 0 doctors.
The most common payment nature for CLONOSEQ is "Unspecified" ($72,000, 91.1% of total).
CLONOSEQ is associated with 3 research studies, including "18281_R" ($45,600).